The implications of single protein detection are significant and may lay the foundation for improved medical therapeutics.
Just months after setting a record for detecting the smallest single virus in solution, researchers at the Polytechnic Institute of New York University (NYU-Poly) have announced a new breakthrough: They used a nano-enhanced version of their patented microcavity biosensor to detect a single cancer marker protein, which is one-sixth the size of the smallest virus, and even smaller molecules below the mass of all known markers. This achievement shatters the previous record, setting a new benchmark for the most sensitive limit of detection, and may significantly advance early disease diagnostics. Unlike current technology, which attaches a fluorescent molecule, or label, to the antigen to allow it to be seen, the new process detects the antigen without an interfering label.
Stephen Arnold, university professor of applied physics and member of the Othmer-Jacobs Department of Chemical and Biomolecular Engineering, published details of the achievement in Nano Letters, a publication of the American Chemical Society.
In 2012, Arnold and his team were able to detect in solution the smallest known RNA virus, MS2, with a mass of 6 attograms. Now, with experimental work by postdoctoral fellow Venkata Dantham and former student David Keng, two proteins have been detected: a human cancer marker protein called Thyroglobulin, with a mass of just 1 attogram, and the bovine form of a common plasma protein, serum albumin, with a far smaller mass of 0.11 attogram. “An attogram is a millionth of a millionth of a millionth of a gram,” said Arnold, “and we believe that our new limit of detection may be smaller than 0.01 attogram.”
This latest milestone builds on a technique pioneered by Arnold and collaborators from NYU-Poly and Fordham University. In 2012, the researchers set the first sizing record by treating a novel biosensor with plasmonic gold nano-receptors, enhancing the electric field of the sensor and allowing even the smallest shifts in resonant frequency to be detected. Their plan was to design a medical diagnostic device capable of identifying a single virus particle in a point-of-care setting, without the use of special assay preparations.
At the time, the notion of detecting a single protein—phenomenally smaller than a virus—was set forth as the ultimate goal.
“Proteins run the body,” explained Arnold. “When the immune system encounters virus, it pumps out huge quantities of antibody proteins, and all cancers generate protein markers. A test capable of detecting a single protein would be the most sensitive diagnostic test imaginable.”
To the surprise of the researchers, examination of their nanoreceptor under a transmission electron microscope revealed that its gold shell surface was covered with random bumps roughly the size of a protein. Computer mapping and simulations created by Stephen Holler, once Arnold’s student and now assistant professor of physics at Fordham University, showed that these irregularities generate their own highly reactive local sensitivity field extending out several nanometers, amplifying the capabilities of the sensor far beyond original predictions. “A virus is far too large to be aided in detection by this field,” Arnold said. “Proteins are just a few nanometers across—exactly the right size to register in this space.”
The implications of single protein detection are significant and may lay the foundation for improved medical therapeutics. Among other advances, Arnold and his colleagues posit that the ability to follow a signal in real time—to actually witness the detection of a single disease marker protein and track its movement—may yield new understanding of how proteins attach to antibodies.
The Latest Bing News on:
Cancer Marker Detection
- Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiationon May 13, 2021 at 7:40 am
Human ribonuclease 1 (hRNase 1) regulates innate immunity, hemostasis and RNA clearance. Here, the authors report an alternative function of hRNase 1 as a secretory ligand of Eph receptor EphA4 to ...
- Apatinib suppresses lung cancer stem-like cells by complex interplay between β-catenin signaling and mitochondrial ROS accumulationon May 12, 2021 at 2:42 pm
The abnormal activation of Wnt/β-catenin signaling plays a critical role in the development of lung cancer, which is also important in the generation and maintenance of lung cancer stem cell (CSC).
- Global Tumor Marker Testing Market 2021 - Featuring Abbott Laboratories, Agilent Technologies and Bio-Rad Among Others - ResearchAndMarkets.comon May 10, 2021 at 10:39 pm
Global Tumor Marker Testing Market - Competitive Shares and Strategic SWOT Analysis, Volume and Sales Segmentation Forecasts for Major Cancer Diagnostic Tests" report has been added to ...
- Indian biotech startup reports early cancer detection breakthroughon May 9, 2021 at 6:56 am
A team of Indian scientists says it has achieved a stunning breakthrough in early cancer diagnosis with a discovery rooted in a contentious segment of cellular biology that, if validated by additional ...
- Breakthrough in cancer with blood test: Tzar Labson May 7, 2021 at 11:39 pm
Singapore based, Tzar Labs, a molecular diagnostic company, along with Mumbai-based Epigeneres Biotechnology, claimed an unprecedented breakthrough in early ...
- Tzar Labs announces breakthrough in early-stage cancer with simple blood teston May 7, 2021 at 6:50 am
Singapore based, Tzar Labs, a molecular diagnostic company, along with Mumbai-based Epigeneres Biotechnology, claimed an unprecedented breakthrough in early-detection and prognosis/diagnosis of cancer ...
- New technology could detect warning signs of breast canceron May 6, 2021 at 5:23 am
A University of Canterbury (UC) student has come up with a new computerized method of reading mammograms that could help radiologists detect warning signs of breast cancer.
- A Better User Experience for Breast Cancer Localizationon May 4, 2021 at 4:55 pm
How a new breast cancer localization technology drastically improves the clinician and patient experience. For 30-some years radiologists and breast surgeons used a procedure known as wire ...
- FDA clears Molli Surgical’s magnetic breast tumor marking deviceon May 3, 2021 at 2:50 pm
Molli Surgical Inc. has won the FDA’s nod for its wire-free localization technology for breast cancer surgery. The company said the Molli system helps radiologists tag cancerous lesions quickly and ...
- Fiducial Markers Market Global Analysis, Statistics, Revenue, Demand and Trend Analysis Research Report by 2027on May 3, 2021 at 12:30 pm
Cancer patients may suffer from an impaired immune system based on type, treatment approach, age, and various other health-related factors, thereby creating a growing demand for fiducial markers.
The Latest Google Headlines on:
Cancer Marker Detection
The Latest Bing News on:
Single protein detection
- Screening for ovarian cancer did not reduce deaths during studyon May 14, 2021 at 3:00 am
Results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) have been published in a report in the medical journal The Lancet.
- Progenity, Inc. (PROG) Q1 2021 Earnings Call Transcripton May 13, 2021 at 10:00 pm
Q1 2021 Earnings CallMay 13, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon everyone. Welcome to the Progenity ...
- Screening for ovarian cancer did not reduce early deathson May 13, 2021 at 6:24 pm
The latest analysis looked at data from more than 200,000 women aged 50-74 at recruitment who were followed up for an average of 16 years. The women were randomly allocated to one of three groups: no ...
- Simultaneous quantitative profiling of clinically relevant immune markers in neonatal stool swabs to reveal inflammationon May 13, 2021 at 3:10 am
An aberrant immune response developed early in life may trigger inflammatory bowel disease (IBD) and food allergies (e.g., celiac disease). Fecal levels of immune markers categorize an inflammatory ...
- Scientists uncover how resistance proteins protect plants from pathogenson May 12, 2021 at 8:00 am
In plants, disease resistance proteins serve as major immune receptors that sense pathogens and pests and trigger robust defense responses. Scientists previously found that one such disease resistance ...
- Ultrasensitive antigen test detects SARS-CoV-2 and influenza viruseson May 11, 2021 at 9:54 am
Researchers at UC Santa Cruz have developed a novel chip-based antigen test that can provide ultrasensitive detection of SARS-CoV-2 and influenza A, the viruses that cause COVID-19 and flu, ...
- Single-cell map offers a new immunotherapy target for lung cancer treatmenton May 10, 2021 at 9:26 pm
Researchers at The University of Texas MD Anderson Cancer Center have developed a first-of-its-kind spatial atlas of early-stage lung cancer and surrounding normal lung tissue at single-cell ...
- Single-cell map of early stage lung cancer and normal lung sheds light on tumor development, new therapeutic targetson May 9, 2021 at 9:00 pm
MD Anderson researchers have developed a first-of-its-kind atlas of early-stage lung cancer and surrounding normal lung tissue. The single-cell map provides a valuable resource to learn about tumor ...
- Robust single-cell discovery of RNA targets of RNA-binding proteins and ribosomeson May 7, 2021 at 9:20 am
Surveying targets by APOBEC-mediated profiling identifies binding sites of RBPs by C-to-U RNA editing. STAMP is isoform specific, can be multiplexed and enables detection of ribosome association in ...
- Rapid and sensitive SARS-CoV-2 detection from saliva using CRISPRon May 3, 2021 at 9:45 pm
In a paper recently uploaded to the preprint server medRxiv by Edward Málaga Trillo et al. (April 29th, 2021), these methods are tested in combination with CRISPR-Cas detection in the field, ...